Dexcom G7 CGM

The Dexcom G7 Continuous Glucose Monitoring (CGM) system is a medical device that helps people with diabetes manage their blood sugar levels by providing real-time glucose data, which can improve treatment outcomes and quality of life. Studies have demonstrated its high accuracy across various settings. In adults with diabetes, the Dexcom G7 showed reliable performance, maintaining consistent readings compared to traditional blood glucose meters. During major surgery and in intensive care units, it maintained its accuracy, suggesting it is suitable for use in critical conditions. The system also performed well in pregnant women with diabetes, providing accurate and reproducible glycemic metrics.

The Dexcom G7's point accuracy was comparable to other widely used CGM systems, and it provided consistent results across different user groups. However, the evidence base is still growing, and more studies are needed to fully understand its long-term effectiveness and potential limitations in diverse populations.

Sources

• Accuracy and Safety of Dexcom G7 Continuous Glucose Monitoring in Adults with Diabetes. (PMID:35157505)
• Performance of the DEXCOM G7 CGM system during and after major surgery. (PMID:40400093)
• Comparison of Point Accuracy Between Two Widely Used Continuous Glucose Monitoring Systems. (PMID:38189290)
• A Comparative Analysis of Glycemic Metrics Derived From Three Continuous Glucose Monitoring Systems. (PMID:40198142)
• Performance of the Dexcom G7 Continuous Glucose Monitoring System in Pregnant Women with Diabetes. (PMID:38315503)
• Dexcom G7 Accuracy and Reproducibility in the Intensive Care Unit. (PMID:40359127)

_Worker-drafted node, Hermes writer enrichment, pending editorial review._